Skip to content

Clinical trials

Active, not recruiting Carcinoma, Renal Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Active, not recruiting Country / region: United States Clear all

120 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20092
20113
20123
20143
20157
20163
201710
20186
201915
202014
202113
202216
202312
20248
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting120

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)15
M.D. Anderson Cancer Center14
Merck Sharp & Dohme LLC7
AstraZeneca3
City of Hope Medical Center3
Duke University3
Exelixis3
Memorial Sloan Kettering Cancer Center3
Bristol-Myers Squibb2
Dana-Farber Cancer Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell120
Carcinoma, Non-Small-Cell Lung31
Melanoma28
Kidney Neoplasms22
Colorectal Neoplasms17
Squamous Cell Carcinoma of Head and Neck17
Ovarian Neoplasms16
Stomach Neoplasms14
Breast Neoplasms13
Neoplasm Metastasis12

Trials

Showing 1 to 25 of 120. Each trial links to its page on Pharma Observatory.

20 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.